Michael Barry
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 44
- Pharmaceutical Economics and Policy 21
-
- HIV/AIDS drug development and treatment 30
- HIV/AIDS Research and Interventions 10
- Co-authors
- David Back (26 shared papers)Fiona Mulcahy (13 shared papers)András Veres (2 shared papers)Andrew T. Campbell (2 shared papers)Sara Gibbons (3 shared papers)Cathal Walsh (30 shared papers)J. Feely (16 shared papers)Lesley Tilson (31 shared papers)
- Journals
- Value in Health (26 papers)British Journal of Clinical Pharmacology (17 papers)PharmacoEconomics (9 papers)AIDS (8 papers)Clinical Infectious Diseases (6 papers)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
Michael Barry
214 papers receiving 5.6k citations
Michael Barry's Hit Papers
Peers
Comparison fields: 5 of 158
- Virology 894
- Infectious Diseases 1.7k
- Pharmacology 402
- Hepatology 328
- Emergency Medicine 358
Countries citing papers authored by Michael Barry
This map shows the geographic impact of Michael Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Barry more than expected).
Fields of papers citing papers by Michael Barry
This network shows the impact of papers produced by Michael Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Barry. The network helps show where Michael Barry may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Barry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure Hit paper breakdown → | 2013 | 408 |
| 2 | 1997 | 297 | |
| 3 | 1999 | 242 | |
| 4 | 2001 | 238 | |
| 5 | 2002 | 226 | |
| 6 | 1997 | 220 | |
| 7 | 2002 | 181 | |
| 8 | 1999 | 173 | |
| 9 | 1997 | 168 | |
| 10 | 2001 | 123 | |
| 11 | 1997 | 123 | |
| 12 | 1999 | 117 | |
| 13 | 2016 | 90 | |
| 14 | 2001 | 87 | |
| 15 | 1996 | 78 | |
| 16 | 1999 | 74 | |
| 17 | 1990 | 67 | |
| 18 | 1969 | 66 | |
| 19 | 2003 | 65 | |
| 20 | 2011 | 64 |
About Michael Barry
Michael Barry is a scholar working on Economics and Econometrics, Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine and General Health Professions, having authored 221 papers that have together received 5.9k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (44 papers), HIV/AIDS drug development and treatment (30 papers), Pharmaceutical Economics and Policy (21 papers), HIV Research and Treatment (17 papers), Hepatitis C virus research (10 papers), HIV/AIDS Research and Interventions (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Forensic Toxicology and Drug Analysis (8 papers). The work is most often cited by research in Virology (894 citations), Infectious Diseases (1.7k citations), Pharmacology (402 citations), Hepatology (328 citations) and Emergency Medicine (358 citations). Michael Barry has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include David Back, Fiona Mulcahy, András Veres, Andrew T. Campbell, Sara Gibbons, Cathal Walsh, J. Feely, Lesley Tilson, Concepta Merry and Máirín Ryan. Their work appears in journals such as Value in Health, British Journal of Clinical Pharmacology, PharmacoEconomics, AIDS and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.